CoChat

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors

Abstract

OBJECTIVE: Cleared blood glucose monitors (BGMs) for personal use may not always deliver levels of accuracy currently specified by international and U.S. regulatory bodies. This study’s objective was to assess the accuracy of 18 such systems cleared by the U.S. Food and Drug Administration representing approximately 90% of commercially available systems used from 2013 to 2015. RESEARCH DESIGN AND METHODS: A total of 1,035 subjects were recruited to have a capillary blood glucose (BG) level measured on six different systems and a reference capillary sample prepared for plasma testing at a reference laboratory. Products were obtained from consumer outlets and tested in three triple-blinded studies. Each of the three participating clinical sites tested a different set of six systems for each of the three studies in a round-robin. In each study, on average, a BGM was tested on 115 subjects. A compliant BG result was defined as within 15% of a reference plasma value (for BG ≥100 mg/dL [5.55 mmol/L]) or within 15 mg/dL (0.83 mmol/L) (for BG <100 mg/dL [5.55 mmol/L]). The proportion of compliant readings in each study was compared against a predetermined accuracy standard similar to, but more lenient than, current regulatory standards. Other metrics of accuracy included the overall compliance proportion; the proportion of extreme outlier readings differing from the reference value by >20%; modified Bland-Altman analysis including average bias, coefficient of variation, and 95% limits of agreement; and proportion of readings with no clinical risk as determined by the Surveillance Error Grid. RESULTS: The different accuracy metrics produced almost identical BGM rankings. Six of the 18 systems met the predetermined accuracy standard in all three studies, 5 systems met it in two studies, and 3 met it in one study. Four BGMs did not meet the accuracy standard in any of the three studies. CONCLUSIONS: Cleared BGMs do not always meet the level of analytical accuracy currently required for regulatory clearance. This information could assist patients, professionals, and payers in choosing products and regulators in evaluating postclearance performance.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc17-1960

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. Fein, 2015, 2014-15 Economic Report on Retail, Mail, and Specialty Pharmacies

Cited by

See all 155

Metadata

Authors
Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A.
Affiliations
  • Mills-Peninsula Medical Center, Diabetes Research Institute, San Mateo, CA
  • Joan Lee Parkes Consulting, Inc., Bristol, IN
  • University of Virginia (US)
  • Sansum Diabetes Research Institute (US)
  • Rainier Clinical Research Center (US)
  • Diablo Clinical Research (US)
  • AMCR Institute (US)
  • Vanderbilt University (US)
  • University of California, San Francisco (US)
Corresponding author
Klonoff, David C.
Venue
Diabetes Care
Published
2018-06-13
Volume
41
Issue
8
Pages
1681-1688
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2808448482
Cited by
144
References
12
Citations by year
2026: 9 · 2025: 13 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 24 · 2020: 26 · 2019: 25 · 2018: 6
FWCI
16.23
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
Abbott Diabetes Care
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
blood glucose meters, point-of-care glucose testing, accuracy, regulatory approval, capillary blood glucose, Bland-Altman analysis, consumer product evaluation, diabetes self-monitoring
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Commerce, Diabetes Mellitus, Double-Blind Method, Equipment and Supplies, Female, Hematocrit, Humans, Male, Middle Aged, Patient Compliance, Prediabetic State, Reference Values, United States, United States Food and Drug Administration, Blood Glucose Self-Monitoring, Reproducibility of Results, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.